PPLPHARMAlow · LITIGATION
Piramal Pharma Limited — Disclosure under Regulation 30 of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015
Piramal Pharma Limited · Healthcare · filed 29 Sept, 10:58 IST
Why we say this
The facts in the filing itself.
- Disclosure under Regulation 30 of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015
- Filed with NSE on 2026-09-29 under the category "Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company". Classified from that category alone — no model and no PDF, because NSE has no category for losing an order or reducing capacity.